Endocrinology, Vol 137, 3-12, Copyright © 1996 by Endocrine Society

ARTICLES

Chronic administration of neuropeptide Y into the lateral ventricle inhibits both the pituitary-testicular axis and growth hormone and insulin-like growth factor I secretion in intact adult male rats

DD Pierroz, C Catzeflis, AC Aebi, JE Rivier and ML Aubert
Department of Pediatrics, University of Geneva School of Medicine, Switzerland.

Neuropeptide Y (NPY) is known to be involved in the central regulation of appetite, sexual behavior, and reproductive function. Whereas central administration of NPY strongly stimulates feeding in satiated animals, diet restriction or other unfavorable metabolic situations, such as diabetes, produce enhanced NPY gene expression and NPY release in the hypothalamus. Numerous studies have indicated that acute central administration of NPY results in various actions on LH secretion in the rat, either stimulatory or inhibitory. We recently demonstrated that chronic infusion of NPY into the lateral ventricle of adult intact female rats profoundly inhibited both the gonadotropic and somatotropic axes, with disruption of estrous cyclicity. Furthermore, we showed that central chronic infusion of NPY delayed sexual maturation in female rats. To analyze the effects of the same type of chronic NPY treatment on the pituitary-testicular axis, 45-day-old Sprague-Dawley male rats were implanted with stainless steel cannulas in the right lateral ventricle. Ten days later, Alzet osmotic minipumps were filled with different NPY solutions, adjusted to deliver 6, 18, or 36 micrograms/day, connected to the intracerebroventricular (icv) cannula, and sc implanted dorsally. The effects of these treatments were evaluated over 7 days. In one case, rats were castrated 5 days after initiation of NPY treatment, and the effect of castration was evaluated 2 days later. Chronic icv infusion of NPY produced the expected dose- related increases in food intake from 33.0 +/- 0.9 (basal) to 53.4 +/- 3.3 g/day (18 micrograms NPY/day) and body weight gain (5.7 +/- 0.7 to 10.5 +/- 1.2 d/day). As in female rats, this orexigenic action of NPY resulted in a significant dose-related decrease in pituitary weight, from 12.4 +/- 0.7 to 9.9 +/- 0.4 mg. The 7-day NPY infusion produced highly significant decreases in seminal vesicle weight (853 +/- 77 to 230 +/- 31 mg) and testis weight (3.82 +/- 0.09 to 3.18 +/- 0.15 g; P = 0.003). Plasma levels of testosterone (231 +/- 71 to 48 +/- 13 ng/dl), LH (20.7 +/- 3.7 to 9.1 +/- 1.2 ng/ml), and FSH (282 +/- 17 to 190 +/- 18 ng/ml) were markedly decreased at the 18 micrograms/day dosage, as also demonstrated for the 36 micrograms/day dosage. None of these effects was observed if vehicle was infused into the lateral ventricle instead of the NPY solution. When bilateral orchidectomy was performed 5 days after initiation of the NPY infusion (18 micrograms/day), the immediate LH and FSH rises usually seen after castration were seriously blunted.(ABSTRACT TRUNCATED AT 400 WORDS)

This article has been cited by other articles:

				C. Wagner, S R. Caplan, and G. S Tannenbaum Interactions of ghrelin signaling pathways with the GH neuroendocrine axis: a new and experimentally tested model J. Mol. Endocrinol., September 1, 2009; 43(3): 105 - 119. [Abstract] [Full Text] [PDF]

				A. M. van den Hoek, C. van Heijningen, J. P. Schroder-van der Elst, D. M. Ouwens, L. M. Havekes, J. A. Romijn, A. Kalsbeek, and H. Pijl Intracerebroventricular Administration of Neuropeptide Y Induces Hepatic Insulin Resistance via Sympathetic Innervation Diabetes, September 1, 2008; 57(9): 2304 - 2310. [Abstract] [Full Text] [PDF]

				B. M. McGowan, S. A. Stanley, J. Donovan, E. L. Thompson, M. Patterson, N. M. Semjonous, J. V. Gardiner, K. G. Murphy, M. A. Ghatei, and S. R. Bloom Relaxin-3 stimulates the hypothalamic-pituitary-gonadal axis Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E278 - E286. [Abstract] [Full Text] [PDF]

				E. L. Sherman, J. D. Nkrumah, B. M. Murdoch, C. Li, Z. Wang, A. Fu, and S. S. Moore Polymorphisms and haplotypes in the bovine neuropeptide Y, growth hormone receptor, ghrelin, insulin-like growth factor 2, and uncoupling proteins 2 and 3 genes and their associations with measures of growth, performance, feed efficiency, and carcass merit in beef cattle J Anim Sci, January 1, 2008; 86(1): 1 - 16. [Abstract] [Full Text] [PDF]

				L. Pinilla, R. Fernandez-Fernandez, J. Roa, J. M. Castellano, M. Tena-Sempere, and E. Aguilar Selective role of neuropeptide Y receptor subtype Y2 in the control of gonadotropin secretion in the rat Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1385 - E1392. [Abstract] [Full Text] [PDF]

				N. Kakui and K. Kitamura Direct Evidence that Stimulation of Neuropeptide Y Y5 Receptor Activates Hypothalamo-Pituitary-Adrenal Axis in Conscious Rats via both Corticotropin-Releasing Factor- and Arginine Vasopressin-Dependent Pathway Endocrinology, June 1, 2007; 148(6): 2854 - 2862. [Abstract] [Full Text] [PDF]

				S. Lin, E.-J. D. Lin, D. Boey, N. J. Lee, K. Slack, M. J. During, A. Sainsbury, and H. Herzog Fasting Inhibits the Growth and Reproductive Axes via Distinct Y2 and Y4 Receptor-Mediated Pathways Endocrinology, May 1, 2007; 148(5): 2056 - 2065. [Abstract] [Full Text] [PDF]

				R. M. Luque, S. Park, and R. D. Kineman Severity of the Catabolic Condition Differentially Modulates Hypothalamic Expression of Growth Hormone-Releasing Hormone in the Fasted Mouse: Potential Role of Neuropeptide Y and Corticotropin-Releasing Hormone Endocrinology, January 1, 2007; 148(1): 300 - 309. [Abstract] [Full Text] [PDF]

				E.-J. D. Lin, A. Sainsbury, N. J. Lee, D. Boey, M. Couzens, R. Enriquez, K. Slack, R. Bland, M. J. During, and H. Herzog Combined Deletion of Y1, Y2, and Y4 Receptors Prevents Hypothalamic Neuropeptide Y Overexpression-Induced Hyperinsulinemia despite Persistence of Hyperphagia and Obesity Endocrinology, November 1, 2006; 147(11): 5094 - 5101. [Abstract] [Full Text] [PDF]

				T. Komatsu, T. Chiba, H. Yamaza, K. To, H. Toyama, Y. Higami, and I. Shimokawa Effect of leptin on hypothalamic gene expression in calorie-restricted rats. J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2006; 61(9): 890 - 898. [Abstract] [Full Text] [PDF]

				L. Pinilla, R. Fernandez-Fernandez, E. Vigo, V. M. Navarro, J. Roa, J. M. Castellano, R. Pineda, M. Tena-Sempere, and E. Aguilar Stimulatory effect of PYY-(3-36) on gonadotropin secretion is potentiated in fasted rats Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1162 - E1171. [Abstract] [Full Text] [PDF]

				E Kim, S Sohn, M Lee, J Jung, R D Kineman, and S Park Differential responses of the growth hormone axis in two rat models of streptozotocin-induced insulinopenic diabetes J. Endocrinol., February 1, 2006; 188(2): 263 - 270. [Abstract] [Full Text] [PDF]

				J. Iqbal, T. R. Manley, P. Ciofi, and I. J. Clarke Reduction in Adiposity Affects the Extent of Afferent Projections to Growth Hormone-Releasing Hormone and Somatostatin Neurons and the Degree of Colocalization of Neuropeptides in Growth Hormone-Releasing Hormone and Somatostatin Cells of the Ovine Hypothalamus Endocrinology, November 1, 2005; 146(11): 4776 - 4785. [Abstract] [Full Text] [PDF]

				T. Karl, S. Lin, C. Schwarzer, A. Sainsbury, M. Couzens, W. Wittmann, D. Boey, S. von Horsten, and H. Herzog Y1 receptors regulate aggressive behavior by modulating serotonin pathways PNAS, August 24, 2004; 101(34): 12742 - 12747. [Abstract] [Full Text] [PDF]

				A. M. Haqq, D. D. Stadler, R. G. Rosenfeld, K. L. Pratt, D. S. Weigle, R. S. Frayo, S. H. LaFranchi, D. E. Cummings, and J. Q. Purnell Circulating Ghrelin Levels Are Suppressed by Meals and Octreotide Therapy in Children with Prader-Willi Syndrome J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3573 - 3576. [Abstract] [Full Text] [PDF]

				A. Sainsbury, C. Schwarzer, M. Couzens, and H. Herzog Y2 Receptor Deletion Attenuates the Type 2 Diabetic Syndrome of ob/ob Mice Diabetes, December 1, 2002; 51(12): 3420 - 3427. [Abstract] [Full Text] [PDF]

				A. Sainsbury, C. Schwarzer, M. Couzens, A. Jenkins, S. R. Oakes, C. J. Ormandy, and H. Herzog Y4 receptor knockout rescues fertility in ob/ob mice Genes & Dev., May 1, 2002; 16(9): 1077 - 1088. [Abstract] [Full Text] [PDF]

				K. Baran, E. Preston, D. Wilks, G. J. Cooney, E. W. Kraegen, and A. Sainsbury Chronic Central Melanocortin-4 Receptor Antagonism and Central Neuropeptide-Y Infusion in Rats Produce Increased Adiposity by Divergent Pathways Diabetes, January 1, 2002; 51(1): 152 - 158. [Abstract] [Full Text] [PDF]

				J. Kallio, U. Pesonen, M. K. Karvonen, M. Kojima, H. Hosoda, K. Kangawa, and M. Koulu Enhanced Exercise-Induced GH Secretion in Subjects with Pro7 Substitution in the Prepro-NPY J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5348 - 5352. [Abstract] [Full Text] [PDF]

				T. Ichimaru, Y. Mori, and H. Okamura A Possible Role of Neuropeptide Y as a Mediator of Undernutrition to the Hypothalamic Gonadotropin-Releasing Hormone Pulse Generator in Goats Endocrinology, June 1, 2001; 142(6): 2489 - 2498. [Abstract] [Full Text] [PDF]

				C. J. Small, M. S. Kim, S. A. Stanley, J. R.D. Mitchell, K. Murphy, D. G.A. Morgan, M. A. Ghatei, and S. R. Bloom Effects of Chronic Central Nervous System Administration of Agouti-Related Protein in Pair-Fed Animals Diabetes, February 1, 2001; 50(2): 248 - 254. [Abstract] [Full Text]

				P. D. Raposinho, E. Castillo, V. D'alleves, P. Broqua, F. P. Pralong, and M. L. Aubert Chronic Blockade of the Melanocortin 4 Receptor Subtype Leads to Obesity Independently of Neuropeptide Y Action, with No Adverse Effects on the Gonadotropic and Somatotropic Axes Endocrinology, December 1, 2000; 141(12): 4419 - 4427. [Abstract] [Full Text] [PDF]

				M. C. Lebrethon, E. Vandersmissen, A. Gerard, A. S. Parent, J. L. Junien, and J. P. Bourguignon In Vitro Stimulation of the Prepubertal Rat Gonadotropin-Releasing Hormone Pulse Generator by Leptin and Neuropeptide Y through Distinct Mechanisms Endocrinology, April 1, 2000; 141(4): 1464 - 1469. [Abstract] [Full Text] [PDF]

				J. M. Cerda-Reverter, L. A. Sorbera, M. Carrillo, and S. Zanuy Energetic dependence of NPY-induced LH secretion in a teleost fish (Dicentrarchus labrax) Am J Physiol Regulatory Integrative Comp Physiol, December 1, 1999; 277(6): R1627 - R1634. [Abstract] [Full Text] [PDF]

				C. Li, P. Chen, and M. S. Smith Morphological Evidence for Direct Interaction between Arcuate Nucleus Neuropeptide Y (NPY) Neurons and Gonadotropin-Releasing Hormone Neurons and the Possible Involvement of NPY Y1 Receptors Endocrinology, November 1, 1999; 140(11): 5382 - 5390. [Abstract] [Full Text]

				P. D. Raposinho, P. Broqua, D. D. Pierroz, A. Hayward, Y. Dumont, R. Quirion, J.-L. Junien, and M. L. Aubert Evidence That the Inhibition of Luteinizing Hormone Secretion Exerted by Central Administration of Neuropeptide Y (NPY) in the Rat Is Predominantly Mediated by the NPY-Y5 Receptor Subtype Endocrinology, September 1, 1999; 140(9): 4046 - 4055. [Abstract] [Full Text]

				E. E. Muller, V. Locatelli, and D. Cocchi Neuroendocrine Control of Growth Hormone Secretion Physiol Rev, April 1, 1999; 79(2): 511 - 607. [Abstract] [Full Text] [PDF]

				D. D. Pierroz, A. C. Aebi, I. T. Huhtaniemi, and M. L. Aubert Many LH peaks are needed to physiologically stimulate testosterone secretion: modulation by fasting and NPY Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E603 - E610. [Abstract] [Full Text] [PDF]

				C. Li, P. Chen, and M. S. Smith The Acute Suckling Stimulus Induces Expression of Neuropeptide Y (NPY) in Cells in the Dorsomedial Hypothalamus and Increases NPY Expression in the Arcuate Nucleus Endocrinology, April 1, 1998; 139(4): 1645 - 1652. [Abstract] [Full Text] [PDF]

				C. J. Small, D. G. A. Morgan, K. Meeran, M. M. Heath, I. Gunn, C. M. B. Edwards, J. Gardiner, G. M. Taylor, J. D. Hurley, M. Rossi, et al. Peptide analogue studies of the hypothalamic neuropeptide Y receptor mediating pituitary adrenocorticotrophic hormone release PNAS, October 14, 1997; 94(21): 11686 - 11691. [Abstract] [Full Text] [PDF]

				W. F. Blum, P. Englaro, S. Hanitsch, A. Juul, N. T. Hertel, J. Muller, N. E. Skakkebak, M. L. Heiman, M. Birkett, A. M. Attanasio, et al. Plasma Leptin Levels in Healthy Children and Adolescents: Dependence on Body Mass Index, Body Fat Mass, Gender, Pubertal Stage, and Testosterone J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2904 - 2910. [Abstract] [Full Text] [PDF]

				M. W. Schwartz and R. J. Seeley Neuroendocrine Responses to Starvation and Weight Loss N. Engl. J. Med., June 19, 1997; 336(25): 1802 - 1811. [Full Text] [PDF]

				D. O'Shea, D. G. A. Morgan, K. Meeran, C. M. B. Edwards, M. D. Turton, S. J. Choi, M. M. Heath, I. Gunn, G. M. Taylor, J. K. Howard, et al. Neuropeptide Y Induced Feeding in the Rat Is Mediated by a Novel Receptor Endocrinology, January 1, 1997; 138(1): 196 - 202. [Abstract] [Full Text] [PDF]

				J. C. Erickson, G. Hollopeter, and R. D. Palmiter Attenuation of the Obesity Syndrome of ob/ob Mice by the Loss of Neuropeptide Y Science, December 6, 1996; 274(5293): 1704 - 1707. [Abstract] [Full Text]